






































Journal of the American College of Cardiology Vol. 56, No. 1, 2010
© 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
PQUARTERLY FOCUS ISSUE: PREVENTION/OUTCOMES
Editorial Comment
What Does Heart Disease Have to Do With Anxiety?*
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bhis issue of the Journal features 2 unusual reports concern-
ng anxiety as risk factors for subsequent cardiac disease. I
ay “unusual reports” because they do not focus on how
urrent anxiety levels are related to current cardiac symp-
oms. Rather, they focus on the extent to which anxiety
ymptoms forecast cardiac disease far into the future.
See pages 31 and 38
The meta-analysis by Roest et al. (1) suggests that anxiety
ymptoms predict incident cardiac events, years in advance
f their onset. Combining reports from 20 studies that
ncompassed approximately 250,000 individuals, the au-
hors found that anxious persons were at increased risk for
oronary heart disease (CHD) many years in the future. It
as not that an anxious person today had a myocardial
nfarction tomorrow but rather that anxiety symptoms
redicted CHD onset—on average, 11 years into the future.
he report describes clearly and succinctly virtually every
tep of the analysis. Moreover, the findings are not limited
o American observations but, rather, included studies from
orway, the Netherlands, Russia, Sweden, Japan, and the
nited Kingdom. Interestingly, the risk gradient persisted
n analyses that adjusted for demographic and risk-
romoting (e.g., smoking) behaviors. That is, the future
ardiac risks associated with anxiety were not explained by
edentary lifestyle, poor education, and so forth.
The report by Janszky et al. (2) also found that anxiety
isorders predicted future coronary disease. The authors
xamined data from a cohort of approximately 50,000
wedish men who were examined for military service and
ho were subsequently followed for an average of 37 years.
lthough depression was not a predictor for subsequent
oronary disease in this sample, anxiety disorders were
ignificantly predictive of subsequent coronary disease, even
fter controlling for baseline differences in blood pressure,
moking, and the like. That this was a nationwide sample of
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xtends the generalizability of the findings. In addition, the
tudy did not rely just on self-report measures of anxiety.
ather, individuals who reported psychiatric symptoms
ere secondarily screened by a psychiatrist, and an anxiety
iagnosis was made only when the recruit met International
lassification of Diseases-8th Revision criteria for anxiety
eurosis.
hat is one to make of such findings? What is it about
nxiety that makes it so toxic to the cardiovascular system?
hat answer, alas, cannot be provided by these studies. One
onders about mediating physiology. Obvious candidate
ediators include sympathetic nervous system activity and
arious inflammatory markers, but anxiety’s physiological
everberations are extensive indeed. Recent studies, for
nstance, raise the question of whether sleep interruption (a
ommon accompaniment of anxiety) might contribute to
iverse manifestations of cardiovascular disease (CVD) (3)
r whether diverse mood factors affect endothelial function
4). Alternatively, one wonders about underlying factors
ommon to both CVD and anxiety. The uncomfortable fact
s that there is a substantial amount of unexplained variance
n the incidence of CHD, despite considering traditional
isk factors such as smoking and high cholesterol. New risk
actors need to be carefully scrutinized for clinical utility. It
ight be one thing if the new risk factor is rarely encoun-
ered, but if the risk is both statistically significant and
ommonly encountered, then it might be all the more
mportant to study. In this regard, anxiety disorders are as
revalent as hypertension. The lifetime prevalence of anxi-
ty disorders is approximately 28% (5). Anxiety disorders are
major affliction of the young, but even in older individuals,
hey are common disorders, with an estimated 12-month
revalence of 10% (6). Regardless of their high prevalence
nd possible cardiac risk, anxiety disorders are associated
ith considerable suffering, disability, and impaired quality
f life. Their impact on global functioning is roughly akin to
hat of low back pain or leg ulcers. When anxiety coexists
ith depression, the corresponding impact on quality of life
s even worse, along the lines of the impact of chronic
bstructive pulmonary disease (7).
It is odd that anxiety symptoms can be such a strong
eacon, lighting the way to future coronary disease decades
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Heart Disease and Anxiety June 29, 2010:47–8ffects on transient physiology (blood pressure, palpitations,
ngina). But it is intriguing indeed to note that one single
ssessment of anxiety casts such a long shadow decades into
he future.
n the meantime, how should these observations guide
ractice? These observations on anxiety come at a time
hen psychiatry is once again redrawing diagnostic guide-
ines in the Diagnostic and Statistical Manual. For decades,
he Diagnostic and Statistical Manual has differentiated
etween anxiety disorders and depressive disorders; yet
ncreasingly, clinicians are pointing out that these disorders
arely occur in isolation and that the distress associated with
hem increases synergistically when both sets of symptoms
oexist in the bosom of 1 unfortunate patient.
The studies in this issue of the Journal suggest that, by the
ime patients with symptoms of CHD present themselves to
cardiologist, early-life anxiety might have already taken its
oll. Anxiety hurts. It hurts subjectively, and these studies
uggest that anxiety hurts physiologically. Physicians are
requently timid about assessing emotional symptoms. It is
dd that we thread catheters, ablate lesions, and give rectal
xams but are uncomfortable asking our patients about their
ives. Assessment tools like the Prime-MD (8) are readily
vailable, with their easy-to-ask questions such as “have you
een bothered a lot by ‘nerves’ or feeling anxious or on
dge?” Such questions open the door. Findings such as those
escribed in these articles suggest that including this infor-
ation in our clinical assessments might be relevant for the
iagnosis (and prevention) of CVD.
I well remember my gross anatomy days, when we
issected confidently, intent upon following anatomical
tructures and disregarding fat tissue as having little mean-
ng or importance. We now appreciate how important fat is,
ven though it lacks the structural “integrity” of a muscle
roup. Emotional factors are even harder to grasp. They
on’t show up, even amorphously in a cadaver but are
normously influential in terms of their impact on function-
ng. That emotional factors affect the heart is obvious. How
hey do so and how to mitigate these effects remains to be
iscovered. These studies did not address treatment strate-
ies, and thus it remains to be determined whether treat-
K
aents aimed at alleviating anxiety (e.g., medications, psy-
hotherapy, stress reduction, lifestyle alteration) would
educe the cardiovascular risk (Is our fate sealed as soon as
e have an early-life anxiety disorder?), but until proven
therwise, the wise clinician might “assume” that treatment
f anxiety disorders might have benefits beyond immediate
ymptomatic and functional improvement.
cknowledgments
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